The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $5.19

Today's change+0.03 +0.58%
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $5.19

Today's change+0.03 +0.58%
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.

Infinity Pharmaceuticals Inc up (U.S.)$0.03

Infinity Pharmaceuticals Inc closed up Friday by (U.S.)$0.03 or 0.58% to (U.S.)$5.19. Over the last five days, shares have gained 7.45%, but are down 33.89% for the last year to date. Shares have underperformed the S&P 500 by 59.29% during the last year.

Key company metrics

  • Open(U.S.) $5.16
  • Previous close(U.S.) $5.16
  • High(U.S.) $5.23
  • Low(U.S.) $4.97
  • Bid / Ask(U.S.) $5.12 / (U.S.) $8.31
  • YTD % change-33.89%
  • Volume138,055
  • Average volume (10-day)353,084
  • Average volume (1-month)375,628
  • Average volume (3-month)572,156
  • 52-week range(U.S.) $4.50 to (U.S.) $13.32
  • Beta1.52
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.52
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue99915
Total other revenue--------
Total revenue99915
Gross profit--------
Total cost of revenue--------
Total operating expense50484743
Selling / general / administrative119109
Research & development39393834
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-41-3943-39
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-41-3943-38
Income after tax-41-3943-38
Income tax, total--00--
Net income-41-3943-38
Total adjustments to net income-----1--
Net income before extra. items-41-3943-38
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-41-3942-38
Inc. avail. to common incl. extra. items-41-3942-38
Diluted net income-41-3942-38
Dilution adjustment----0--
Diluted weighted average shares49495049
Diluted EPS excluding extraordinary itemsvalue per share-0.82-0.800.84-0.78
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.82-0.800.84-0.78
R